Clinical Trial: Clinical Evaluation of the Photoallergy Potential of Atralin Gel
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Clinical Evaluation of the Photoallergy Potential of Atralin Gel (Tretinoin Gel 0.05%)
Brief Summary: To assess the potential of tretinoin gel 0.05% and its vehicle to produce photoallergic reactions, measured as skin reactions following induction and challenge.
Detailed Summary:
Sponsor: Coria Laboratories, Ltd.
Current Primary Outcome: UV Induced skin irritation [ Time Frame: 4 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Coria Laboratories, Ltd.
Dates:
Date Received: January 8, 2008
Date Started: January 2008
Date Completion:
Last Updated: May 5, 2008
Last Verified: February 2008